163 related articles for article (PubMed ID: 18469354)
1. Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer.
Yang J; Li Y; Khoury T; Alrawi S; Goodrich DW; Tan D
Ann Clin Lab Sci; 2008; 38(2):105-12. PubMed ID: 18469354
[TBL] [Abstract][Full Text] [Related]
2. Human hHpr1/p84/Thoc1 regulates transcriptional elongation and physically links RNA polymerase II and RNA processing factors.
Li Y; Wang X; Zhang X; Goodrich DW
Mol Cell Biol; 2005 May; 25(10):4023-33. PubMed ID: 15870275
[TBL] [Abstract][Full Text] [Related]
3. The Thoc1 ribonucleoprotein and prostate cancer progression.
Chinnam M; Wang Y; Zhang X; Gold DL; Khoury T; Nikitin AY; Foster BA; Li Y; Bshara W; Morrison CD; Payne Ondracek RD; Mohler JL; Goodrich DW
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25296641
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.
Yang J; Ramnath N; Moysich KB; Asch HL; Swede H; Alrawi SJ; Huberman J; Geradts J; Brooks JS; Tan D
BMC Cancer; 2006 Aug; 6():203. PubMed ID: 16882345
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancer.
Liu C; Yue B; Yuan C; Zhao S; Fang C; Yu Y; Yan D
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):53-8. PubMed ID: 26545775
[TBL] [Abstract][Full Text] [Related]
7. High Sam68 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Xu Y; Sun N; Zhang M; Xie J; Jiang Z
Clin Transl Oncol; 2014 Oct; 16(10):886-91. PubMed ID: 24522888
[TBL] [Abstract][Full Text] [Related]
8. Thoc1 inhibits cell growth via induction of cell cycle arrest and apoptosis in lung cancer cells.
Wan J; Zou S; Hu M; Zhu R; Xu J; Jiao Y; Fan S
Mol Med Rep; 2014 Jun; 9(6):2321-7. PubMed ID: 24682263
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
10. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
Huang YT; Heist RS; Chirieac LR; Lin X; Skaug V; Zienolddiny S; Haugen A; Wu MC; Wang Z; Su L; Asomaning K; Christiani DC
J Clin Oncol; 2009 Jun; 27(16):2660-7. PubMed ID: 19414679
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer.
Qin H; Ni Y; Tong J; Zhao J; Zhou X; Cai W; Liang J; Yao X
Med Oncol; 2014 Aug; 31(8):142. PubMed ID: 25048725
[TBL] [Abstract][Full Text] [Related]
14. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
15. AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non-small cell lung cancer: Results of a retrospective study.
Liu Y; Tian J; Qin D; Liu J; Xie Y
J Clin Lab Anal; 2020 Apr; 34(4):e23128. PubMed ID: 31782840
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs.
Xu JY; Lu S; Xu XY; Hu SL; Li B; Li WX; Chang JY
Tumour Biol; 2016 Aug; 37(8):10349-56. PubMed ID: 26846099
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of PD-L1 and c-Myc in non-small cell lung cancer.
Zhou C; Che G; Zheng X; Qiu J; Xie Z; Cong Y; Pei X; Zhang H; Sun H; Ma H
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2663-2674. PubMed ID: 31541338
[TBL] [Abstract][Full Text] [Related]
19. NCAPH is negatively associated with Mcl‑1 in non‑small cell lung cancer.
Xiong Q; Fan S; Duan L; Liu B; Jiang X; Chen X; Xiong C; Tao Q; Wang J; Zhang H; Chen C; Duan Y
Mol Med Rep; 2020 Oct; 22(4):2916-2924. PubMed ID: 32945371
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]